Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, Wegovy's side effects ease within two to four weeks of starting or after a dose increase. The GI effects — nausea, loose stools, queasiness — tend to peak in the first few days and fade as your body adjusts. They rarely disappear overnight, but the pattern is predictable: most people find the worst of it passes well before the next pen is due. These are prescription-only medicines. A GPhC-registered prescriber reviews every consultation before treatment is approved, and part of that conversation is setting realistic expectations about what to expect and when.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Imagine your Wegovy arrives on a Monday. By Wednesday evening, you've had your first injection, and by Thursday you're wondering whether you feel slightly off or whether you're imagining it. That's a very common report. The nausea tends to arrive gently at first, often described less as vomiting and more as a background queasiness, fullness that sits a little too long after eating, or a mild reluctance to eat at all.
This is semaglutide doing what it's licensed to do: slowing gastric emptying and signalling satiety to the brain. The NHS patient information for semaglutide lists nausea, vomiting, diarrhoea, constipation, and indigestion as the most common effects. Most people experience one or two, not all of them. Fatigue and headache are also reported in the first days, if tiredness is your main concern, there's more detail on how long Wegovy fatigue lasts and what tends to help.
The key point: week one is rarely the worst week. That distinction usually belongs to the first dose increase, because your body is adapting to a new level again. Knowing that in advance makes it considerably easier to sit through.
Wegovy is titrated gradually, starting at 0.25mg and moving through 0.5mg, 1.0mg, 1.7mg, and up to 2.4mg (or 7.2mg with the newer single-dose 7.2mg pen approved by the MHRA in April 2026), with a minimum of roughly four weeks at each level. The reason for the slow climb is precisely to give the body time to adapt.
After most dose increases, any GI effects that had settled tend to reappear briefly, usually for five to fourteen days. Think of it as a reset rather than a relapse. Body aches and general fatigue can also return at this point; some of the underlying mechanisms are covered on our page about Wegovy and body aches. By the time many people reach their maintenance dose, their body has been through several of these short adjustment windows and the effects at each step tend to be milder than the one before.
Timing matters more than people expect. If a dose increase falls just before a holiday or a big work week, the first few days can feel harder to manage. That's worth factoring in when you and your prescriber are planning the titration schedule.
Most GI symptoms settle on their own. A handful do not, and those deserve attention rather than patience.
Diarrhoea that continues for more than a week or causes genuine dehydration is worth discussing with a clinician. The fuller picture of how long Wegovy-related diarrhoea typically lasts includes practical steps that often help, but persistent symptoms need assessment, not just reassurance. Similarly, nausea that is so severe it prevents you from keeping fluids down is not a normal adjustment effect, contact a clinician promptly.
The MHRA's guidance on GLP-1 medicines flags acute pancreatitis as a known risk: if you develop severe stomach pain that won't settle and seems to reach through to your back, with or without vomiting, get medical help the same day. Don't wait to see if it passes. This is not common, but it is serious. You can report any suspected side effect, including those not listed in the leaflet, through the Yellow Card scheme, the information genuinely helps regulators track patterns across large populations.
For a broader picture of everything that can happen and when, our full Wegovy side effects guide covers the complete reported profile.
For the majority of people, yes, at least to the point where they stop interfering with daily life. Once someone has been stable on their maintenance dose for several weeks, the GI landscape usually quietens considerably. Some people notice a brief flicker if they eat a very large or high-fat meal, which is a natural consequence of slowed gastric emptying. That tends to become less of an issue as eating habits shift.
A smaller number of people find certain symptoms persist longer. Whether that reflects individual variation, the specific dose, or other factors isn't always clear, and it is one of the things worth raising at a clinical review rather than simply stopping treatment without guidance. The question of whether Wegovy side effects fully resolve is worth exploring in more detail if you're deciding whether to continue. The same mechanisms apply to semaglutide more broadly, which is why the experience across semaglutide side effects follows a similar arc.
Our prescribers discuss this kind of thing as a matter of course during consultations, not as a hurdle, but because understanding what to expect makes treatment easier to sustain. If you're considering starting, check your eligibility and the conversation starts there.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.